About SenoRx
SenoRx is a company based in Irvine (United States) founded in 1998 was acquired by CR Bard in May 2010. SenoRx operates in a competitive market with competitors including Elucent Medical, Cianna Medical, OncoStem, Curasight and PreludeDx, among others.
- Headquarter Irvine, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Senorx Llc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of SenoRx
Investments & Acquisitions by SenoRx
Financial Statements - SenoRx
Senorx Comparisons
Competitors of SenoRx
SenoRx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Elucent Medical, Cianna Medical, OncoStem, Curasight and PreludeDx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Develops smart surgical guidance systems with in-body spatial intelligence for accuracy.
|
|
| domain | founded_year | HQ Location |
Breast brachytherapy devices and surgical guidance systems are developed.
|
|
| domain | founded_year | HQ Location |
Prognostic tests for cancer detection and recurrence risk are developed.
|
|
| domain | founded_year | HQ Location |
uPAR-based PET ligands for breast cancer imaging are developed.
|
|
| domain | founded_year | HQ Location |
Risk assessment tests for early-stage breast cancer are provided.
|
|
| domain | founded_year | HQ Location |
Telomere tests for aging detection and cellular senescence are provided.
|
Latest news on Senorx
Frequently Asked Questions about SenoRx
SenoRx was founded in 1998.
SenoRx is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
SenoRx(previously known as BiopSolation Medical) designs, develops, manufactures and markets minimally invasive devices for the diagnosis and treatment of breast cancer. SenoRx (NASDAQ: SENO) completed its initial public offering of common stock in March 2007. Its products include the EnCor vacuum-assisted breast biopsy system, the Contura Multi-Lumen Balloon (MLB) applicator for delivering radiation to the tissue surrounding the lumpectomy cavity following surgery for breast cancer, and SenoSonix, which combines ultrasound and vacuum-assisted biopsy in one system. It offers vacuum-assisted breast biopsy systems, breast tissue markers, breast localization wires, core needle biopsy products, sentinel node detection products, and disposable bone and aspiration biopsy needles. The companys products are used with ultrasound, stereotactic, and MRI. SenoRx sells several of its products through distribution partners in more than 30 countries outside the U.S. and Canada. The companys line of breast care products includes biopsy disposables, biopsy capital equipment, diagnostic adjunct products and therapeutic disposables. SenoRx was acquired by CR Bard in 2010 for 213M.
SenoRx has 1 investor. Key investors include CR Bard.